Stifel Downgrades Apellis Pharmaceuticals (APLS) to Hold

March 31, 2026 4:08 PM

Stifel analyst Annabel Samimy downgraded Apellis Pharmaceuticals (NASDAQ: APLS) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found